Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Mapping | 2 | 2009 | 23 | 0.520 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2009 | 77 | 0.510 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 15 | 0.370 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 12 | 0.310 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 34 | 0.300 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 1 | 0.290 |
Why?
|
| Motor Cortex | 1 | 2009 | 3 | 0.290 |
Why?
|
| Auditory Cortex | 1 | 2005 | 1 | 0.230 |
Why?
|
| Language | 1 | 2005 | 12 | 0.230 |
Why?
|
| Sex Characteristics | 1 | 2005 | 14 | 0.230 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 6 | 0.190 |
Why?
|
| Humans | 11 | 2010 | 2957 | 0.180 |
Why?
|
| Adult | 7 | 2009 | 794 | 0.180 |
Why?
|
| Patient Care Planning | 1 | 2001 | 1 | 0.170 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 4 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 9 | 0.170 |
Why?
|
| Kidney | 1 | 2001 | 13 | 0.170 |
Why?
|
| Female | 7 | 2009 | 1724 | 0.150 |
Why?
|
| Male | 9 | 2009 | 1860 | 0.140 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 11 | 0.120 |
Why?
|
| Middle Aged | 6 | 2008 | 792 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 74 | 0.080 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 6 | 0.080 |
Why?
|
| Contrast Media | 1 | 2010 | 10 | 0.080 |
Why?
|
| Reference Values | 1 | 2009 | 28 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 47 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 83 | 0.070 |
Why?
|
| Subclavian Artery | 1 | 2008 | 1 | 0.070 |
Why?
|
| Vertebral Artery | 1 | 2008 | 1 | 0.070 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 3 | 0.070 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 3 | 0.070 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 3 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 85 | 0.060 |
Why?
|
| Echo-Planar Imaging | 1 | 2005 | 1 | 0.060 |
Why?
|
| Dominance, Cerebral | 1 | 2005 | 3 | 0.060 |
Why?
|
| Frontal Sinus | 1 | 2003 | 1 | 0.050 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 1 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 1 | 0.040 |
Why?
|
| Renal Artery | 1 | 2001 | 1 | 0.040 |
Why?
|
| Pelvis | 1 | 2001 | 3 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 24 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2001 | 33 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 8 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 1 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 1999 | 3 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 1 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 1 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 3 | 0.040 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 1 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 1995 | 4 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 1 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 1 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 1 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 6 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 1 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 1 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 1 | 0.030 |
Why?
|
| Arteritis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 4 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2008 | 119 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2008 | 167 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Prevalence | 1 | 2003 | 39 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 21 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 105 | 0.010 |
Why?
|
| Aged | 2 | 1995 | 956 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 1 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 2 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 3 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1999 | 2 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 8 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 5 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 14 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 1 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 3 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 3 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 2 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 12 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 25 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1999 | 203 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 234 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 1050 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 1 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 2 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 7 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 106 | 0.010 |
Why?
|
| Adolescent | 1 | 1995 | 247 | 0.010 |
Why?
|
| Acute Disease | 1 | 1994 | 26 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 147 | 0.010 |
Why?
|